High clonal diversity and spatial genetic admixture in early prostate cancer and surrounding normal tissue.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
24 Apr 2024
Historique:
received: 10 08 2023
accepted: 09 04 2024
medline: 25 4 2024
pubmed: 25 4 2024
entrez: 24 4 2024
Statut: epublish

Résumé

Somatic copy number alterations (SCNAs) are pervasive in advanced human cancers, but their prevalence and spatial distribution in early-stage, localized tumors and their surrounding normal tissues are poorly characterized. Here, we perform multi-region, single-cell DNA sequencing to characterize the SCNA landscape across tumor-rich and normal tissue in two male patients with localized prostate cancer. We identify two distinct karyotypes: 'pseudo-diploid' cells harboring few SCNAs and highly aneuploid cells. Pseudo-diploid cells form numerous small-sized subclones ranging from highly spatially localized to broadly spread subclones. In contrast, aneuploid cells do not form subclones and are detected throughout the prostate, including normal tissue regions. Highly localized pseudo-diploid subclones are confined within tumor-rich regions and carry deletions in multiple tumor-suppressor genes. Our study reveals that SCNAs are widespread in normal and tumor regions across the prostate in localized prostate cancer patients and suggests that a subset of pseudo-diploid cells drive tumorigenesis in the aging prostate.

Identifiants

pubmed: 38658552
doi: 10.1038/s41467-024-47664-z
pii: 10.1038/s41467-024-47664-z
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

3475

Subventions

Organisme : Cancerfonden (Swedish Cancer Society)
ID : CAN 2018/728
Organisme : Cancerfonden (Swedish Cancer Society)
ID : 19 0130 Pj 03 H
Organisme : Stiftelsen för Strategisk Forskning (Swedish Foundation for Strategic Research)
ID : BD15_0095
Organisme : Stiftelsen för Strategisk Forskning (Swedish Foundation for Strategic Research)
ID : BD15_0095

Informations de copyright

© 2024. The Author(s).

Références

Watkins, T. B. K. et al. Pervasive chromosomal instability and karyotype order in tumour evolution. Nature 587, 126–132 (2020).
pubmed: 32879494 pmcid: 7611706 doi: 10.1038/s41586-020-2698-6
Knouse, K. A., Davoli, T., Elledge, S. J. & Amon, A. Aneuploidy in cancer: seq-ing answers to old questions. Annu. Rev. Cancer Biol. 1, 335–354 (2017).
doi: 10.1146/annurev-cancerbio-042616-072231
Harbers, L. et al. Somatic copy number alterations in human cancers: an analysis of publicly available data from the cancer genome atlas. Front. Oncol. 11, 700568 (2021).
pubmed: 34395272 pmcid: 8355892 doi: 10.3389/fonc.2021.700568
Baca, S. C. et al. Punctuated evolution of prostate cancer genomes. Cell 153, 666–677 (2013).
pubmed: 23622249 pmcid: 3690918 doi: 10.1016/j.cell.2013.03.021
Gao, R. et al. Punctuated copy number evolution and clonal stasis in triple-negative breast cancer. Nat. Genet. 48, 1119–1130 (2016).
pubmed: 27526321 pmcid: 5042845 doi: 10.1038/ng.3641
Sottoriva, A. et al. A Big Bang model of human colorectal tumor growth. Nat. Genet. 47, 209–216 (2015).
pubmed: 25665006 pmcid: 4575589 doi: 10.1038/ng.3214
Bollen, Y. et al. Reconstructing single-cell karyotype alterations in colorectal cancer identifies punctuated and gradual diversification patterns. Nat. Genet. 53, 1187–1195 (2021).
pubmed: 34211178 pmcid: 8346364 doi: 10.1038/s41588-021-00891-2
Killcoyne, S. et al. Genomic copy number predicts esophageal cancer years before transformation. Nat. Med. 26, 1726–1732 (2020).
pubmed: 32895572 pmcid: 7116403 doi: 10.1038/s41591-020-1033-y
Cervigne, N. K. et al. Recurrent genomic alterations in sequential progressive leukoplakia and oral cancer: drivers of oral tumorigenesis? Hum. Mol. Genet. 23, 2618–2628 (2014).
pubmed: 24403051 pmcid: 3990162 doi: 10.1093/hmg/ddt657
Espiritu, S. M. G. et al. The evolutionary landscape of localized prostate cancers drives clinical aggression. Cell 173, 1003–1013.e15 (2018).
pubmed: 29681457 doi: 10.1016/j.cell.2018.03.029
Rebello, R. J. et al. Prostate cancer. Nat. Rev. Dis. Primer 7, 9 (2021).
doi: 10.1038/s41572-020-00243-0
Boutros, P. C. et al. Spatial genomic heterogeneity within localized, multifocal prostate cancer. Nat. Genet. 47, 736–745 (2015).
pubmed: 26005866 doi: 10.1038/ng.3315
Cooper, C. S. et al. Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. Nat. Genet. 47, 367–372 (2015).
pubmed: 25730763 pmcid: 4380509 doi: 10.1038/ng.3221
Ståhl, P. L. et al. Visualization and analysis of gene expression in tissue sections by spatial transcriptomics. Science 353, 78–82 (2016).
pubmed: 27365449 doi: 10.1126/science.aaf2403
Erickson, A. et al. Spatially resolved clonal copy number alterations in benign and malignant tissue. Nature 608, 360–367 (2022).
pubmed: 35948708 pmcid: 9365699 doi: 10.1038/s41586-022-05023-2
Zhang, X. et al. CUTseq is a versatile method for preparing multiplexed DNA sequencing libraries from low-input samples. Nat. Commun. 10, 4732 (2019).
pubmed: 31628304 pmcid: 6802095 doi: 10.1038/s41467-019-12570-2
Zong, C., Lu, S., Chapman, A. R. & Xie, X. S. Genome-wide detection of single-nucleotide and copy-number variations of a single human cell. Science 338, 1622–1626 (2012).
pubmed: 23258894 pmcid: 3600412 doi: 10.1126/science.1229164
Minussi, D. C. et al. Breast tumours maintain a reservoir of subclonal diversity during expansion. Nature 592, 302–308 (2021).
pubmed: 33762732 pmcid: 8049101 doi: 10.1038/s41586-021-03357-x
Makboul, R. et al. Transmembrane and tetratricopeptide repeat containing 4 is a novel diagnostic marker for prostate cancer with high specificity and sensitivity. Cells 10, 1029 (2021).
pubmed: 33925440 pmcid: 8146280 doi: 10.3390/cells10051029
Schneider, M. P. et al. scAbsolute: Measuring Single-Cell Ploidy and Replication Status. https://doi.org/10.1101/2022.11.14.516440 (2022).
Kaufmann, T. L. et al. MEDICC2: whole-genome doubling aware copy-number phylogenies for cancer evolution. Genome Biol 23, 241 (2022).
pubmed: 36376909 pmcid: 9661799 doi: 10.1186/s13059-022-02794-9
McInnes, L., Healy, J. & Melville, J. UMAP: Uniform manifold approximation and projection for dimension reduction. Nat. Biotechnol. 37, 38–44 (2019).
Gelali, E. et al. iFISH is a publically available resource enabling versatile DNA FISH to study genome architecture. Nat. Commun. 10, 1636 (2019).
pubmed: 30967549 pmcid: 6456570 doi: 10.1038/s41467-019-09616-w
Wernersson, E. et al. Deconwolf enables high-performance deconvolution of widefield fluorescence microscopy images. Preprint at https://doi.org/10.21203/rs.3.rs-1303463/v1 (2022).
Sondka, Z. et al. The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers. Nat. Rev. Cancer 18, 696–705 (2018).
pubmed: 30293088 pmcid: 6450507 doi: 10.1038/s41568-018-0060-1
Adams, E. J. et al. FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes. Nature 571, 408–412 (2019).
pubmed: 31243370 pmcid: 6661172 doi: 10.1038/s41586-019-1318-9
Calissi, G., Lam, E. W.-F. & Link, W. Therapeutic strategies targeting FOXO transcription factors. Nat. Rev. Drug Discov. 20, 21–38 (2021).
pubmed: 33173189 doi: 10.1038/s41573-020-0088-2
Zhao, X. et al. Integrative analysis of cancer driver genes in prostate adenocarcinoma. Mol. Med. Rep. 19, 2707–2715 (2019).
pubmed: 30720096 pmcid: 6423600
Hamid, A. A. et al. Compound genomic alterations of tp53, pten, and rb1 tumor suppressors in localized and metastatic prostate cancer. Eur. Urol. 76, 89–97 (2019).
pubmed: 30553611 doi: 10.1016/j.eururo.2018.11.045
Yang, Y. et al. Loss of FOXO1 cooperates with TMPRSS2-ERG overexpression to promote prostate tumorigenesis and cell invasion. Cancer Res 77, 6524–6537 (2017).
pubmed: 28986382 pmcid: 5712249 doi: 10.1158/0008-5472.CAN-17-0686
Miao, C. et al. RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer. Sci. Adv. 8, eabl9794 (2022).
pubmed: 35179959 pmcid: 8856618 doi: 10.1126/sciadv.abl9794
Li, W. et al. Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers. Cancer Res 71, 2162–2171 (2011).
pubmed: 21278236 pmcid: 3070402 doi: 10.1158/0008-5472.CAN-10-3268
Gao, S. et al. Forkhead domain mutations in FOXA1 drive prostate cancer progression. Cell Res 29, 770–772 (2019).
pubmed: 31324883 pmcid: 6796877 doi: 10.1038/s41422-019-0203-2
Hieronymus, H. et al. Deletion of 3p13-14 locus spanning FOXP1 to SHQ1 cooperates with PTEN loss in prostate oncogenesis. Nat. Commun. 8, 1081 (2017).
pubmed: 29057879 pmcid: 5651901 doi: 10.1038/s41467-017-01198-9
Takayama, K.-I. et al. Integrative analysis of FOXP1 function reveals a tumor-suppressive effect in prostate cancer. Mol. Endocrinol. Baltim. Md 28, 2012–2024 (2014).
doi: 10.1210/me.2014-1171
Epstein, J. I. Prostate cancer grading: a decade after the 2005 modified system. Mod. Pathol. Off. J. U. S. Can. Acad. Pathol. Inc 31, S47–S63 (2018).
Laks, E. et al. Clonal decomposition and DNA replication states defined by scaled single-cell genome sequencing. Cell 179, 1207–1221.e22 (2019).
pubmed: 31730858 pmcid: 6912164 doi: 10.1016/j.cell.2019.10.026
Zachariadis, V., Cheng, H., Andrews, N. & Enge, M. A highly scalable method for joint whole-genome sequencing and gene-expression profiling of single cells. Mol. Cell 80, 541–553.e5 (2020).
pubmed: 33068522 doi: 10.1016/j.molcel.2020.09.025
Wang, K. et al. Archival single-cell genomics reveals persistent subclones during DCIS progression. Cell 186, 3968–3982.e15 (2023).
pubmed: 37586362 doi: 10.1016/j.cell.2023.07.024
Bolhaqueiro, A. C. F. et al. Ongoing chromosomal instability and karyotype evolution in human colorectal cancer organoids. Nat. Genet. 51, 824–834 (2019).
pubmed: 31036964 doi: 10.1038/s41588-019-0399-6
Kester, L. et al. Integration of multiple lineage measurements from the same cell reconstructs parallel tumor evolution. Cell Genomics 2, 100096 (2022).
pubmed: 36778661 pmcid: 9903660 doi: 10.1016/j.xgen.2022.100096
Gothe, H. J. et al. Spatial chromosome folding and active transcription drive DNA fragility and formation of oncogenic MLL translocations. Mol. Cell 75, 267–283.e12 (2019).
pubmed: 31202576 doi: 10.1016/j.molcel.2019.05.015
Epstein, J. I., Amin, M. B., Reuter, V. E. & Humphrey, P. A. Contemporary gleason grading of prostatic carcinoma: an update with discussion on practical issues to implement the 2014 international society of urological pathology (isup) consensus conference on gleason grading of prostatic carcinoma. Am. J. Surg. Pathol. 41, e1–e7 (2017).
pubmed: 28177964 doi: 10.1097/PAS.0000000000000820
Tan, L. Determining the 3D genome structure of a single mammalian cell with Dip-C. STAR Protoc 2, 100622 (2021).
pubmed: 34195675 pmcid: 8225968 doi: 10.1016/j.xpro.2021.100622
Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinforma. Oxf. Engl. 34, i884–i890 (2018).
doi: 10.1093/bioinformatics/bty560
Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Preprint at ArXiv13033997 Q-Bio https://github.com/lh3/bwa (2013).
Li, H. et al. The sequence alignment/Map format and SAMtools. Bioinforma. Oxf. Engl. 25, 2078–2079 (2009).
doi: 10.1093/bioinformatics/btp352
Smith, T., Heger, A. & Sudbery, I. UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy. Genome Res 27, 491–499 (2017).
pubmed: 28100584 pmcid: 5340976 doi: 10.1101/gr.209601.116
McKenna, A. et al. The genome analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20, 1297–1303 (2010).
pubmed: 20644199 pmcid: 2928508 doi: 10.1101/gr.107524.110
Köster, J. & Rahmann, S. Snakemake-a scalable bioinformatics workflow engine. Bioinforma. Oxf. Engl. 34, 3600 (2018).
doi: 10.1093/bioinformatics/bty350
Olshen, A. B., Venkatraman, E. S., Lucito, R. & Wigler, M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostat. Oxf. Engl. 5, 557–572 (2004).
Nilsen, G. et al. Copynumber: Efficient algorithms for single- and multi-track copy number segmentation. BMC Genomics 13, 591 (2012).
pubmed: 23442169 pmcid: 3582591 doi: 10.1186/1471-2164-13-591
Fridlyand, J. & Dimitrov, P. aCGH: Classes and functions for Array Comparative Genomic Hybridization data. R package version 1.80.0 https://doi.org/10.18129/B9.bioc.aCGH , https://bioconductor.org/packages/aCGH (2023).
Rigatti, S. J. Random Forest. J. Insur. Med. N. Y. N 47, 31–39 (2017).
Cutler, F. original by L. B. and A. & Wiener, R. port by A. L. and M. randomForest: Breiman and Cutler’s random forests for classification and regression. https://doi.org/10.1023/A:1010933404324 (2022).
Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinforma. Oxf. Engl. 26, 841–842 (2010).
doi: 10.1093/bioinformatics/btq033
Balaban, M., Moshiri, N., Mai, U., Jia, X. & Mirarab, S. TreeCluster: Clustering biological sequences using phylogenetic trees. PloS One 14, e0221068 (2019).
pubmed: 31437182 pmcid: 6705769 doi: 10.1371/journal.pone.0221068
Hahsler, M., Piekenbrock, M. & Doran, D. dbscan: Fast Density-Based Clustering with R. J. Stat. Softw. 91, 1–30 (2019).
doi: 10.18637/jss.v091.i01
Signorell, A. et al. DescTools: Tools for Descriptive Statistics. R package version 0.99.54, https://github.com/AndriSignorell/DescTools/ , https://andrisignorell.github.io/DescTools/ (2024).
Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2, 401–404 (2012).
pubmed: 22588877 doi: 10.1158/2159-8290.CD-12-0095
Colaprico A. et al. TCGAbiolinks: An R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 44, e71 (2016).
Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol 12, R41 (2011).
pubmed: 21527027 pmcid: 3218867 doi: 10.1186/gb-2011-12-4-r41
Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).
pubmed: 29203879 pmcid: 5715110 doi: 10.1038/s41598-017-17204-5
Rueden, C. T. et al. ImageJ2: ImageJ for the next generation of scientific image data. BMC Bioinformatics 18, 529 (2017).
pubmed: 29187165 pmcid: 5708080 doi: 10.1186/s12859-017-1934-z
Harbers, L. High clonal diversity and spatial genetic admixture in early prostate cancer and surrounding normal tissue. Source Data: processed data required to reproduce all analyses and recreate figures. Figshare, https://doi.org/10.6084/m9.figshare.23675517.v1 (2024).
Harbers, L. High clonal diversity and spatial genetic admixture in early prostate cancer and surrounding normal tissue. GitHub, https://doi.org/10.5281/zenodo.10674169 (2024).

Auteurs

Ning Zhang (N)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, 17177, Sweden.
Science for Life Laboratory, Stockholm, 17177, Sweden.
Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Ji'nan, 250012, China.

Luuk Harbers (L)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, 17177, Sweden.
Science for Life Laboratory, Stockholm, 17177, Sweden.

Michele Simonetti (M)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, 17177, Sweden.
Science for Life Laboratory, Stockholm, 17177, Sweden.

Constantin Diekmann (C)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, 17177, Sweden.
Science for Life Laboratory, Stockholm, 17177, Sweden.

Quentin Verron (Q)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, 17177, Sweden.
Science for Life Laboratory, Stockholm, 17177, Sweden.

Enrico Berrino (E)

Candiolo Cancer Institute, FPO - IRCCS, Candiolo, SP142, km 3,95, 10060, Turin, Italy.
Department of Medical Sciences, University of Turin, Turin, Italy.

Sara E Bellomo (SE)

Candiolo Cancer Institute, FPO - IRCCS, Candiolo, SP142, km 3,95, 10060, Turin, Italy.
Department of Oncology, University of Turin, Turin, Italy.

Gabriel M C Longo (GMC)

Institute of Molecular Biology (IMB), Mainz, 55128, Germany.

Michael Ratz (M)

Department of Cell and Molecular Biology, Karolinska Institute, Stockholm, 17177, Sweden.

Niklas Schultz (N)

Science for Life Laboratory, Stockholm, 17177, Sweden.
Department of Oncology and Pathology, Karolinska Institutet, Stockholm, 17177, Sweden.

Firas Tarish (F)

Södersjukhuset, Stockholm, 11883, Sweden.

Peng Su (P)

Department of Pathology, Qilu Hospital of Shandong University, Ji'nan, 250012, China.

Bo Han (B)

Department of Pathology, Qilu Hospital of Shandong University, Ji'nan, 250012, China.

Wanzhong Wang (W)

Department of Oncology and Pathology, Karolinska Institutet, Stockholm, 17177, Sweden.

Sofia Onorato (S)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, 17177, Sweden.
Science for Life Laboratory, Stockholm, 17177, Sweden.

Dora Grassini (D)

Department of Medical Sciences, University of Turin, Turin, Italy.

Roberto Ballarino (R)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, 17177, Sweden.
Science for Life Laboratory, Stockholm, 17177, Sweden.

Silvia Giordano (S)

Candiolo Cancer Institute, FPO - IRCCS, Candiolo, SP142, km 3,95, 10060, Turin, Italy.
Department of Oncology, University of Turin, Turin, Italy.

Qifeng Yang (Q)

Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Ji'nan, 250012, China.

Anna Sapino (A)

Candiolo Cancer Institute, FPO - IRCCS, Candiolo, SP142, km 3,95, 10060, Turin, Italy.
Department of Medical Sciences, University of Turin, Turin, Italy.

Jonas Frisén (J)

Department of Cell and Molecular Biology, Karolinska Institute, Stockholm, 17177, Sweden.

Kanar Alkass (K)

Department of Cell and Molecular Biology, Karolinska Institute, Stockholm, 17177, Sweden.
Department of Oncology and Pathology, Karolinska Institutet, Stockholm, 17177, Sweden.

Henrik Druid (H)

Department of Oncology and Pathology, Karolinska Institutet, Stockholm, 17177, Sweden.

Vassilis Roukos (V)

Institute of Molecular Biology (IMB), Mainz, 55128, Germany.
Department of General Biology, Medical School, University of Patras, Patras, Greece.

Thomas Helleday (T)

Science for Life Laboratory, Stockholm, 17177, Sweden.
Department of Oncology and Pathology, Karolinska Institutet, Stockholm, 17177, Sweden.

Caterina Marchiò (C)

Candiolo Cancer Institute, FPO - IRCCS, Candiolo, SP142, km 3,95, 10060, Turin, Italy.
Department of Medical Sciences, University of Turin, Turin, Italy.

Magda Bienko (M)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, 17177, Sweden.
Science for Life Laboratory, Stockholm, 17177, Sweden.
Human Technopole, Viale Rita Levi-Montalcini 1, 20157, Milan, Italy.

Nicola Crosetto (N)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, 17177, Sweden. nicola.crosetto@ki.se.
Science for Life Laboratory, Stockholm, 17177, Sweden. nicola.crosetto@ki.se.
Human Technopole, Viale Rita Levi-Montalcini 1, 20157, Milan, Italy. nicola.crosetto@ki.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH